Expression of Receptors for Cholecystokinin and Other Ca2+-Mobilizing Hormones in Xenopus Oocytes (Biosynthesis) JOHN A

Total Page:16

File Type:pdf, Size:1020Kb

Expression of Receptors for Cholecystokinin and Other Ca2+-Mobilizing Hormones in Xenopus Oocytes (Biosynthesis) JOHN A Proc. Nati. Acad. Sci. USA Vol. 85, pp. 4939-4943, July 1988 Physiological Sciences Expression of receptors for cholecystokinin and other Ca2+-mobilizing hormones in Xenopus oocytes (biosynthesis) JOHN A. WILLIAMS*, DENNIS J. MCCHESNEY, M. CLARA CALAYAG, VISHWANATH R. LINGAPPA, AND CRAIG D. LOGSDONt Departments of Physiology and Medicine, University of California, San Francisco, CA 94143; and Cell Biology Laboratory, Mount Zion Hospital and Medical Center, San Francisco, CA 94120 Communicated by Viktor Mutt, March 14, 1988 ABSTRACT The expression of receptors for cholecystoki- by the electrophysiological effects of receptor occupancy. nin (CCK) and other similar acting Ca2 -mobilizing hormones We made use of the fact that the receptors for CCK mobilize was studied in Xenopus laevis oocytes. Poly(A)+ RNA was intracellular Ca2+ to develop a simple functional assay based prepared from pancreatic AR42J cells, which normally express on the increased efflux of 45Ca2. Oocytes injected with receptors for CCK and bombesin and the RNA injected into mRNA from a CCK-sensitive pancreas cell line (AR42J cells) oocytes. The presence of these pancreatic receptors on the were shown to express CCK receptors with normal CCK oocytes was then demonstrated by hormone-induced mobiliza- analog and antagonist sensitivity. We also present data tion of &5Ca2 CCK receptors were present 1 day (maxnum, showing that the CCK receptor is encoded by a 3-kilobase 2 days) after injection ofRNA and were generally proportional (kb) mRNA and that the assay developed can also document to the amount of poly(A)+ RNA injected (1-50 ng). Oocyte the expression of receptors for bombesin, angiotensin, and CCK receptors retained selectivity for CCK analogs (CCK8 > vasopressin when RNA from appropriate cells is injected. unsulfated CCK8 > CCK4) and were blocked by the specific CCK receptor antagonist CR 1409. When poly(A)+ RNA was METHODS subjected to size fractionation on sucrose gradients, activity- inducing CCK receptors showed a single peak centered at 3 Cell Culture. AR42J cells were maintained as subconfluent kilobases. The generality of this oocyte system for expressing cultures in Dulbecco's modified Eagle's medium containing Ca2+-mobilizing hormone receptors was further shown by penicillin, streptomycin, amphotericin B, and 10o fetal bovine expression of a response to bombesin after injection of AR42J serum (from the Cell Culture Facility, University ofCalifornia, cell RNA and a response to vasopressin and angiotensin 11 when San Francisco, CA). In some cases, cells were treated with poly(A)+ RNA from rat liver was injected. No response to CCK dexamethasone (100 nM) for 48 hr prior to harvesting. was demonstrable after injection of liver RNA, demonstrating PreparationofmRNA. RNA was isolated from AR42J cells, the specificity of this assay. rat pancreas, and rat liver by the method of Chirgwin et al. (21). AR42J cells (2 x 107) were suspended by trypsinization, Cholecystokinin (CCK) is a gastrointestinal hormone that washed in phosphate-buffered saline, lysed in 10 ml of a acts to regulate secretion of the exocrine and endocrine buffer containing 4 M guanidine thiocyanate, 50 mM Tris HCl pancreas, gallbladder contraction, and gastric emptying (1, (pH 7.5), 10 mM EDTA, 0.5% sodium lauroylsarcosine, and 2). Moreover, it is also present in brain and other neural tissue 0.1 M mercaptoethanol. RNA was separated from DNA and where it appears to function as a neurotransmitter or neuro- protein by centrifugation through cesium chloride (22). modulator (3-6). The actions of CCK on peripheral target Poly(A) + RNA was obtained by oligo(dT)-cellulose chroma- cells are mediated by enhanced inositol phospholipid turn- tography (23) and was quantified spectrophotometrically over, diacylglycerol formation, and mobilization of intracel- (A26 unit = 40 jig of RNA per ml). lular Ca2" (7). These actions are initiated by specific mem- Size fractionation of RNA was carried out by sucrose brane receptors, which have been characterized as to num- gradient centrifugation as follows: Sucrose gradients (10- ber, specificity, size, and subunit composition (8-12). 50%) were prepared by a modification ofthe method ofLuthe Although the CCK receptor has been solubilized with reten- (24). Briefly, five solutions of 10%o, 20%o,'30%o, 40%o, and 50% tion of binding, complete purification has proven difficult. sucrose (wt/vol) were prepared in a buffer consisting of 50 In the present work, we have concentrated instead on the mM Tris'HCl (pH 7.6), 50 mM KCl, and 5 mM EDTA, and mRNA encoding the receptor. While most cell-free systems 2.5 ml ofeach was sequentially added to quick-seal centrifuge will not correctly synthesize and process membrane recep- tubes (16 x 76 mm) (Beckman Instruments) and quick frozen tors to a functional state, cellular systems such as the on dry ice. Gradients were thawed at 40C for at least 12 hr Xenopus oocyte are able to do so (13). Oocytes, by nature of prior to use. Poly(A)+ RNA (100 tug) was dissolved in H20, their size, can be readily injected and have been shown, after heated to 70'C for 30 min, and fractionated by centrifugation injection ofmRNA or cDNA, to express foreign receptors for at 55,000 rpm for 16 hr in a Beckman Ti7O rotor. Fractions epidermal growth factor, insulin, nicotinic cholinergic neu- (=0.5 ml) were collected from the bottoms of the tubes and rotransmitters, serotonin, substance P, and other neurotrans- precipitated in ethanol. mitters (14-20). While epidermal growth factor and insulin For qualitative analysis, fractions were usually pooled and receptors have generally been recognized by immunoprecip- either injected into oocytes or translated in a wheat germ itation with specific antibodies, the presence of foreign neurotransmitter receptors has generally been documented Abbreviation: CCK, cholecystokinin. *To whom reprint requests should be sent at present address: Department ofPhysiology, 7744 Medical Sciences II, University of The publication costs of this article were defrayed in part by page charge Michigan, Ann Arbor, MI 48109. payment. This article must therefore be hereby marked "advertisement" tPresent address: Department ofPhysiology, University ofMichigan in accordance with 18 U.S.C. §1734 solely to indicate this fact. Medical School, Ann Arbor, MI 48109. 4939 Downloaded by guest on September 28, 2021 4940 Physiological Sciences: Williams et al. Proc. Natl. Acad. Sci. USA 85 (1988) cell-free system (25). in the latter case, the products were When oocytes were injected with mRNA from AR42J cells, then separated by polyacrylamide gel electrophoresis (26). they responded with increased45Ca2+ efflux to CCK and to For determination of the average size of mRNA molecules in a lesser extent to bombesin (Fig. 1). This increased efflux was each fraction, total rat pancreas RNA was fractionated in the maximal in the first 5min and subsided over the next 30min. same manner and the fractions were then electrophoresed on Uninjected oocytes or those injected with H20 responded to a 1.2% agarose gel and stained with ethidium bromide, and neither hormone, although they still responded to carbachol. the bands visualized by UV light were compared to an RNA To determine the time course of responsiveness to CCK sizing ladder (Bethesda Research Laboratories). after mRNA injection, oocytes were studied immediately after Oocyte Injection and Culture. Mature oocyte-positive fe- injection and at daily intervals. Although a significant increase male Xenopus laevis were obtained from Xenopus I (Ann in45Ca2` efflux was always observed after 1 day, the maximal Arbor, MI), maintained in dechlorinated tap water, and fed response was observed after 2 or 3 days (Fig. 2). Most Purina Trout Chow twice weekly. Animals were anesthetized experiments were therefore carried out 2 days after injection, in 0.3% Tricaine solution and ovarian tissue was removed via since at longer times some oocytes appeared to deteriorate. an abdominal incision.Oocytes were teased free under a The magnitude of the response varied between batches of dissecting microscope and large oocytes (Dumont stage V- oocytes from a 4- to 60-fold increase in 45Ca2+ efflux, but VI) were selected for use and stored in modified Barth's within each assay results were quite consistent between wells. saline solution (MBSH) with Hepes buffer (pH 7.4), genta- When oocytes were injected with various amounts of AR42J mycin, and penicillin/streptomycin (27). mRNA, there was a dose-dependent response in CCK- After 24 hr at 18'C, oocytes were examined under a induced45Ca2+ efflux over the range of 1 to 50 ng of injected dissecting microscope, damaged oocytes were removed, and mRNA not To ensure a maximum response, healthy appearing ones were prepared for microinjection (data shown). essentially as described (27).Oocyteswere injected in the oocytes were injected in most cases with 50 ng of mRNA, vegetal pole with 50 nl of ultrapure water or water containing although when it was desired to assess relative mRNA activity poly(A)+ RNA, usually at 1ug/jul. After injection, oocytes in size fractions, lesser amounts were used. were stored at 18'C in MBSH containing 10%6 fetal calf serum Further Characterization ofOocyte CCK Receptors. The that had been dialyzed against MBSH; this medium was properties of CCK receptors on AR42J cells have been changed daily. At the indicated time, usually 48 hr after characterized and are generally similar to those on normal injection, oocytes were washed three times with fresh MBSH pancreas (30). We next tested whether CCK receptors on without serum and then used for the45Ca2+ efflux assay. oocytes preserved the agonist and antagonist selectivity of 4'Ca2" Efflux Assay.Oocytes were incubated in 1 ml of their parent cell. The sulfated CCK octapeptide increased MBSH containing45Ca2 + (50, Ci/ml; 1 Ci = 37 GBq) for 2.5 45Ca2 + efflux over the concentration range of 10-10 to10-7 hr at18°C. They were then washed three times with MBSH M.
Recommended publications
  • Actions of Vasoactive Intestinal Peptide on the Rat Adrenal Zona Glomerulosa
    51 Actions of vasoactive intestinal peptide on the rat adrenal zona glomerulosa J P Hinson, J R Puddefoot and S Kapas1 Molecular and Cellular Biology Section, Division of Biomedical Sciences, St Bartholomew’s and The Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, Mile End Road, London E1 4NS, UK 1Oral Diseases Research Centre, St Bartholomew’s and The Royal London School of Medicine and Dentistry, 2 Newark Street, London E1 2AT, UK (Requests for offprints should be addressed to J P Hinson) Abstract Previous studies, by this group and others, have shown that The response to VIP in adrenals obtained from rats fed vasoactive intestinal peptide (VIP) stimulates aldosterone a low sodium diet was also investigated. Previous studies secretion, and that the actions of VIP on aldosterone have found that adrenals from animals on a low sodium secretion by the rat adrenal cortex are blocked by â diet exhibit increased responsiveness to VIP. Specific VIP adrenergic antagonists, suggesting that VIP may act by binding sites were identified, although the concentration the local release of catecholamines. The present studies or affinity of binding sites in the low sodium group was not were designed to test this hypothesis further, by measur- significantly different from the controls. In the low sodium ing catecholamine release by adrenal capsular tissue in group VIP was found to increase catecholamine release to response to VIP stimulation. the same extent as in the control group, however, in Using intact capsular tissue it was found that VIP caused contrast to the control group, the adrenal response to VIP a dose-dependent increase in aldosterone secretion, with a was not altered by adrenergic antagonists in the low concomitant increase in both adrenaline and noradrenaline sodium group.
    [Show full text]
  • Angiotensin II Protocol
    Angiotensin II (Giapreza ™) Protocol Background Sepsis and septic shock are medical emergencies that affect millions of people each year and killing as many as 1 in 4.1 The cornerstones of therapy are fluid resuscitation, early appropriate antibiotics, source control if needed and vasopressors. A small portion of patients fail to respond to these therapies and develop refractory shock. The definition of refractory septic shock varies in the literature but is generally considered to be hypotension, with end-organ dysfunction, requiring high-dose vasopressor support.2 The associated mortality of refractory septic shock is up to 60% and as high as 80-90% in patients requiring more than 1 mcg/kg/min of norepinephrine.2,3 Patients who develop refractory septic shock comprise a very small portion of the population in large randomized controlled trials therefore limited data is available regarding outcomes and management. Indications: Angiotensin II (Ang II) is a vasoconstrictor used to increase blood pressure in adults with septic or other distributive shock. Administration: Starting dose of 5 (nanograms) ng/kg/min intravenously via central line only. Titration: Every 5 minutes by increments of 5 ng/kg/min as needed. Maximum dose should not exceed 80 ng/kg/min (During the first 3 hours of administration); after the first 3 hours the maintenance (maximum) dose is 40 ng/kg/min. Monitoring: Critical care setting only with telemetry, arterial blood pressure, and continuous SpO2 monitoring. DVT Prophylaxis should be started (unless contraindicated)
    [Show full text]
  • Pulmonary Clearance of Vasoactive Intestinal Peptide
    Thorax: first published as 10.1136/thx.41.2.88 on 1 February 1986. Downloaded from Thorax 1986;41:88-93 Pulmonary clearance of vasoactive intestinal peptide MICHAEL P BARROWCLIFFE, ALYN MORICE, J GARETH JONES, PETER S SEVER From the Division ofAnaesthesia, Clinical Research Centre, Harrow, and the Department ofClinical Pharmacology and Therapeutics, St Mary's Hospital Medical School, London ABSTRACT Vasoactive intestinal peptide causes bronchodilatation when given intravenously but is less effective in both animals and man when given by inhalation. This difference may be due to poor transit of the peptide across the bronchial epithelium. To test this hypothesis pulmonary clearance of radiolabelled vasoactive intestinal peptide was measured in Sprague Dawley rats and compared with that of pertechnetate (Tc04 ) and diethylene triamine pentaacetate (DTPA). Despite a mole- cular weight (MW) of 3450, iodinated vasoactive intestinal peptide was cleared rapidly from the lungs, with a mean half time (t /2) of 19 minutes after an initial slower phase. This compares with a t'/2 of 10 minutes with Tc04 (MW 163) and a t1/2 of 158 minutes with DTPA (MW 492). The possibility that vasoactive intestinal peptide mediates a non-specific increase in permeability was discounted by the fact that the combination ofvasoactive intestinal peptide and DTPA did not alter DTPA clearance significantly. Chromatography and radioimmunoassay of blood taken after intra- tracheal administration of vasoactive intestinal peptide demonstrated a metabolite but no un- changed peptide. An intravenous injection ofthe peptide disappeared on first pass through the lung. copyright. It is concluded that inhaled vasoactive intestinal peptide lacks efficacy as a bronchodilator not because of slow diffusion to airway smooth muscle but because it is metabolised at an early stage of its passage through the respiratory epithelium.
    [Show full text]
  • Role of the Renin-Angiotensin-Aldosterone
    International Journal of Molecular Sciences Review Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension Natalia Muñoz-Durango 1,†, Cristóbal A. Fuentes 2,†, Andrés E. Castillo 2, Luis Martín González-Gómez 2, Andrea Vecchiola 2, Carlos E. Fardella 2,* and Alexis M. Kalergis 1,2,* 1 Millenium Institute on Immunology and Immunotherapy, Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, 8330025 Santiago, Chile; [email protected] 2 Millenium Institute on Immunology and Immunotherapy, Departamento de Endocrinología, Escuela de Medicina, Pontificia Universidad Católica de Chile, 8330074 Santiago, Chile; [email protected] (C.A.F.); [email protected] (A.E.C.); [email protected] (L.M.G.-G.); [email protected] (A.V.) * Correspondence: [email protected] (C.E.F.); [email protected] (A.M.K.); Tel.: +56-223-543-813 (C.E.F.); +56-223-542-842 (A.M.K.) † These authors contributed equally in this manuscript. Academic Editor: Anastasia Susie Mihailidou Received: 24 March 2016; Accepted: 10 May 2016; Published: 23 June 2016 Abstract: Arterial hypertension is a common condition worldwide and an important predictor of several complicated diseases. Arterial hypertension can be triggered by many factors, including physiological, genetic, and lifestyle causes. Specifically, molecules of the renin-angiotensin-aldosterone system not only play important roles in the control of blood pressure, but they are also associated with the genesis of arterial hypertension, thus constituting a need for pharmacological interventions. Chronic high pressure generates mechanical damage along the vascular system, heart, and kidneys, which are the principal organs affected in this condition.
    [Show full text]
  • Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD
    International Journal of Molecular Sciences Review Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD Anastasia V. Poznyak 1,* , Dwaipayan Bharadwaj 2,3, Gauri Prasad 3, Andrey V. Grechko 4, Margarita A. Sazonova 5 and Alexander N. Orekhov 1,5,6,* 1 Institute for Atherosclerosis Research, Skolkovo Innovative Center, 121609 Moscow, Russia 2 Academy of Scientific and Innovative Research, CSIR-Institute of Genomics and Integrative Biology Campus, New Delhi 110067, India; [email protected] 3 Systems Genomics Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India; [email protected] 4 Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, 14-3 Solyanka Street, 109240 Moscow, Russia; [email protected] 5 Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia; [email protected] 6 Institute of Human Morphology, 3 Tsyurupa Street, 117418 Moscow, Russia * Correspondence: [email protected] (A.V.P.); [email protected] (A.N.O.) Abstract: Atherosclerosis has complex pathogenesis, which involves at least three serious aspects: inflammation, lipid metabolism alterations, and endothelial injury. There are no effective treatment options, as well as preventive measures for atherosclerosis. However, this disease has various severe complications, the most severe of which is cardiovascular disease (CVD). It is important to note, that CVD is among the leading causes of death worldwide. The renin–angiotensin–aldosterone system (RAAS) is an important part of inflammatory response regulation. This system contributes to Citation: Poznyak, A.V.; Bharadwaj, the recruitment of inflammatory cells to the injured site and stimulates the production of various D.; Prasad, G.; Grechko, A.V.; cytokines, such as IL-6, TNF-a, and COX-2.
    [Show full text]
  • Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions
    Molecular Pharmacology Fast Forward. Published on June 2, 2020 as DOI: 10.1124/mol.120.119388 This article has not been copyedited and formatted. The final version may differ from this version. File name: Opioid peptides v45 Date: 5/28/20 Review for Mol Pharm Special Issue celebrating 50 years of INRC Five decades of research on opioid peptides: Current knowledge and unanswered questions Lloyd D. Fricker1, Elyssa B. Margolis2, Ivone Gomes3, Lakshmi A. Devi3 1Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA; E-mail: [email protected] 2Department of Neurology, UCSF Weill Institute for Neurosciences, 675 Nelson Rising Lane, San Francisco, CA 94143, USA; E-mail: [email protected] 3Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, Annenberg Downloaded from Building, One Gustave L. Levy Place, New York, NY 10029, USA; E-mail: [email protected] Running Title: Opioid peptides molpharm.aspetjournals.org Contact info for corresponding author(s): Lloyd Fricker, Ph.D. Department of Molecular Pharmacology Albert Einstein College of Medicine 1300 Morris Park Ave Bronx, NY 10461 Office: 718-430-4225 FAX: 718-430-8922 at ASPET Journals on October 1, 2021 Email: [email protected] Footnotes: The writing of the manuscript was funded in part by NIH grants DA008863 and NS026880 (to LAD) and AA026609 (to EBM). List of nonstandard abbreviations: ACTH Adrenocorticotrophic hormone AgRP Agouti-related peptide (AgRP) α-MSH Alpha-melanocyte stimulating hormone CART Cocaine- and amphetamine-regulated transcript CLIP Corticotropin-like intermediate lobe peptide DAMGO D-Ala2, N-MePhe4, Gly-ol]-enkephalin DOR Delta opioid receptor DPDPE [D-Pen2,D- Pen5]-enkephalin KOR Kappa opioid receptor MOR Mu opioid receptor PDYN Prodynorphin PENK Proenkephalin PET Positron-emission tomography PNOC Pronociceptin POMC Proopiomelanocortin 1 Molecular Pharmacology Fast Forward.
    [Show full text]
  • The Role of Corticotropin-Releasing Hormone at Peripheral Nociceptors: Implications for Pain Modulation
    biomedicines Review The Role of Corticotropin-Releasing Hormone at Peripheral Nociceptors: Implications for Pain Modulation Haiyan Zheng 1, Ji Yeon Lim 1, Jae Young Seong 1 and Sun Wook Hwang 1,2,* 1 Department of Biomedical Sciences, College of Medicine, Korea University, Seoul 02841, Korea; [email protected] (H.Z.); [email protected] (J.Y.L.); [email protected] (J.Y.S.) 2 Department of Physiology, College of Medicine, Korea University, Seoul 02841, Korea * Correspondence: [email protected]; Tel.: +82-2-2286-1204; Fax: +82-2-925-5492 Received: 12 November 2020; Accepted: 15 December 2020; Published: 17 December 2020 Abstract: Peripheral nociceptors and their synaptic partners utilize neuropeptides for signal transmission. Such communication tunes the excitatory and inhibitory function of nociceptor-based circuits, eventually contributing to pain modulation. Corticotropin-releasing hormone (CRH) is the initiator hormone for the conventional hypothalamic-pituitary-adrenal axis, preparing our body for stress insults. Although knowledge of the expression and functional profiles of CRH and its receptors and the outcomes of their interactions has been actively accumulating for many brain regions, those for nociceptors are still under gradual investigation. Currently, based on the evidence of their expressions in nociceptors and their neighboring components, several hypotheses for possible pain modulations are emerging. Here we overview the historical attention to CRH and its receptors on the peripheral nociception and the recent increases in information regarding their roles in tuning pain signals. We also briefly contemplate the possibility that the stress-response paradigm can be locally intrapolated into intercellular communication that is driven by nociceptor neurons.
    [Show full text]
  • Secretion, Degradation, and Elimination of Glucagon-Like
    Secretion, Degradation, and Elimination of Glucagon-Like Peptide 1 and Gastric Inhibitory Polypeptide in Patients with Chronic Renal Insufficiency and Healthy Control Subjects Juris J. Meier,1 Michael A. Nauck,1,2 Daniel Kranz,1 Jens J. Holst,3 Carolyn F. Deacon,3 Dirk Gaeckler,4 Wolfgang E. Schmidt,1 and Baptist Gallwitz1 CRI patients vs. healthy control subjects, respectively. ؎ ؎ Glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP) are important factors in the patho- Plasma half-lives of intact GIP were 6.9 1.4 and 5.0 ؎ ؎ ؍ genesis of type 2 diabetes and have a promising thera- 1.2 min (P 0.31) and 38.1 6.0 and 22.4 3.0 min for ؍ peutic potential. Alterations of their secretion, in vivo the GIP metabolite (P 0.032) for CRI patients vs. degradation, and elimination in patients with chronic healthy control subjects, respectively. Insulin concen- renal insufficiency (CRI) have not yet been character- trations tended to be lower in the patients during all ized. Ten patients with CRI (aged 47 ؎ 15 years, BMI experiments, whereas C-peptide levels tended to be kg/m2, and serum creatinine 2.18 ؎ 0.86 elevated. These data underline the importance of the 2.2 ؎ 24.5 mg/dl) and 10 matched healthy control subjects (aged kidneys for the final elimination of GIP and GLP-1. The years, BMI 24.9 ؎ 3.4 kg/m2, and serum creati- initial dipeptidyl peptidase IV–mediated degradation of 12 ؎ 44 nine 0.89 ؎ 0.10 mg/dl) were included. On separate both hormones is almost unaffected by impairments in occasions, an oral glucose tolerance test (75 g), an renal function.
    [Show full text]
  • Renin-Angiotensin-Aldosterone System (RAAS) and Hypothalamic-Pituitary
    Renin-Angiotensin-Aldosterone System (RAAS) and Hypothalamic-Pituitary- Adrenal Axis (HPAA) in Critically Ill Foals THESIS Presented in Partial Fulfillment of the Requirements for the Degree Master of Science in the Graduate School of The Ohio State University By Katarzyna Agnieszka Dembek Graduate Program in Veterinary Clinical Sciences The Ohio State University 2012 Master's Examination Committee: Associate Professor Ramiro Toribio; Advisor Professor Catherine Kohn Assistant Professor Samuel Hurcombe Copyrighted by Katarzyna Agnieszka Dembek 2012 Abstract Sepsis is a major cause of morbidity and mortality in neonatal foals. Dysfunction of the hypothalamic-pituitary-adrenal axis (HPAA), manifested as relative adrenal insufficiency (RAI), has been associated with sepsis in newborn foals. Information on the renin- angiotensin-aldosterone system (RAAS) is minimal in healthy or sick foals. The HPAA and RAAS are interactive systems, and a relationship between RAAS activation and RAI is well documented in critically ill children, but limited information exists in septic foals. We hypothesized that in critically ill septic newborn foals the RAAS and HPAA will be activated by systemic inflammation and hypoperfusion and the degree of activation will be associated with severity of sepsis and mortality. For this project, 167 (study 1) and 182 (study 2) sick and healthy foals of less than 7 days of age were included. Blood samples were collected on admission from septic (sepsis score >12), sick non-septic (SNS), and healthy foals. Blood concentrations of cortisol, aldosterone, angiotensin-II (ANG-II), corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), adrenocorticotropic hormone (ACTH) and plasma renin activity were determined by immunoassays. Aldosterone, ANG-II, ACTH and cortisol concentrations were higher in septic compared to healthy foals (P<0.05).
    [Show full text]
  • Bioactive Angiotensin Peptides
    Journal of Human Hypertension (1998) 12, 289–293 1998 Stockton Press. All rights reserved 0950-9240/98 $12.00 Bioactive angiotensin peptides I Moeller, AM Allen, S-Y Chai, J Zhuo and FAO Mendelsohn The Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Parkville, Victoria 3052, Australia Angiotensin II is recognised as the principle active pep- involved in memory retention and neuronal develop- tide of the renin-angiotensin system, exerting effects on ment. Furthermore, our demonstration that a globin fluid and electrolyte homeostasis, and cardiovascular fragment, LVV-haemorphin-7, binds with high affinity to control including neural and long term trophic effects. the angiotensin IV binding site and is abundant in the However, recent studies indicate that other angiotensin brain, indicates that this may represent a novel brain peptides such as angiotensin III, angiotensin II (1–7) and neuropeptide system. It now appears, that the renin- angiotensin IV, may have specific actions. Interestingly, angiotensin system is more complex than previously recent work involving angiotensin IV demonstrates that thought and capable of generating multiple, active pep- this peptide binds to specific receptors and may be tides which elicit numerous diverse actions. Keywords: angiotensin metabolites; angiotensin III; angiotensin II(1–7); angiotensin IV; globin Bioactive angiotensin peptides tropic and chronotropic effects and facilitates sympathetic activity.13 The renin-angiotensin system (RAS) was initially Acting on the brain, Ang II induces fluid and salt identified as a circulating humoral system with the ingestion, modulates neuroendocrine systems, effector peptide, angiotensin II (Ang II), generated including vasopressin and corticotropin releasing by an enzymatic cascade.
    [Show full text]
  • Organ, and Pituitary Gland of Hypophysectomized
    Proc. Nati. Acad. Sci. USA Vol. 86, pp. 725-729, January 1989 Neurobiology Angiotensin II receptors in paraventricular nucleus, subfornical organ, and pituitary gland of hypophysectomized, adrenalectomized, and vasopressin-deficient rats (receptor autoradiography/corticotropin-releasing hormone/adrenocorticotropin/blood pressure regulation/Brattleboro rats) EERO CASTRIN AND JUAN M. SAAVEDRA Unit of Preclinical Neuropharmacology, Laboratory of Clinical Science, National Institute of Mental Health, Building 10, Room 2D45, 9000 Rockville Pike, Bethesda, MD 20892 Communicated by Irvine H. Page, October 18, 1988 (receivedfor review August 10, 1988) ABSTRACT Angiotensin II has been implicated in the receptors in circumventricular organs and stimulate the brain regulation of adrenocorticotropin and vasopressin secretion. angiotensin II system, which leads to increased ACTH Angiotensin II may influence the secretion of these hormones release probably through the stimulation of corticotropin- either directly at the pituitary gland or by increasing corti- releasing hormone (CRH) secretion from the hypothalamus cotropin-releasing hormone or vasopressin release from cells (9, 12). that are located in the paraventricular hypothalamic nucleus. The paraventricular nucleus is one ofthe key hypothalamic Pituitary hormone release may also be influenced by circulating nuclei in the neuroendocrine regulation (13). It is divided into angiotensin H through receptors outside the blood-brain distinct, biochemically specific subnuclei (13). Neurons in barrier in the subfornical organ. We have used alterations in the magnocellular subdivision, together with those in the angiotensin II receptors in hypophysectomized, adrenalecto- supraoptic nucleus, produce vasopressin and oxytocin and mized, and vasopressin-deficient Brattleboro rats as indicators project to the posterior pituitary gland, from where the of the activity of angiotensin II in the regulation of adrenocor- hormones are released to the circulation (13).
    [Show full text]
  • Vasopressin Mechanism–Mediated Pressor Responses Caused by Central Angiotensin II in the Ovine Fetus
    0031-3998/04/5605-0756 PEDIATRIC RESEARCH Vol. 56, No. 5, 2004 Copyright © 2004 International Pediatric Research Foundation, Inc. Printed in U.S.A. Vasopressin Mechanism–Mediated Pressor Responses Caused by Central Angiotensin II in the Ovine Fetus LIJUN SHI, CATALINA GUERRA, JIAMING YAO, AND ZHICE XU Harbor-UCLA Medical Center and Research and Education Institute, Torrance, CA 90502 [L.S., C.G., J.Y. Z.X.]; and Soochaw University School of Medicine, Suzhou 215007, China [Z.X.] ABSTRACT AVP not only influences renal water excretion but also has receptor antagonist had no effect on either fetal or maternal profound cardiovascular effects in adults. Our recent studies have baseline BP. However, intracerebroventricular Ang II–increased demonstrated that central angiotensin induced fetal pressor re- BP was partially inhibited, although not completely abolished, by sponses accompanied with AVP release. However, little is the V1-receptor blockade. In contrast, fetal i.v. infusion of known of hormonal mechanisms in angiotensin-mediated fetal V2-receptor antagonist had no effect on the pressor responses blood pressure (BP) changes. The present study determined AVP induced by central Ang II. The results suggest that the central mechanisms in central angiotensin-mediated fetal pressor re- Ang II–mediated pressor responses at the last third of gestation is sponses. The V1-receptor antagonist or V2-receptor antagonist mediated partially by the AVP mechanism via V1 not V2 was infused intravenously into the ovine fetus at 90% gestation. receptors. (Pediatr Res 56: 756–762, 2004) Angiotensin II (Ang II; 1.5 ␮g/kg) was then injected intracere- broventricularly into the chronically instrumented fetus.
    [Show full text]